Pralatrexate Impurities are unwanted substances that may be present in batches of Pralatrexate, a chemotherapy drug used to treat certain types of cancer. These impurities can impact the safety and efficacy of the drug, and it is important to monitor and control their levels during the manufacturing process. Pralatrexate Impurities can include degradation products, residual solvents, and other contaminants, and must be identified and quantified through rigorous testing and analysis.
